Hypertensive Heart DiseaseNCT06524440
Hypertensive Heart Disease in DR Congo
An observational study of Hypertensive Heart Disease, run by Association of Future African Neurosurgeons, Yaounde, Cameroon at 1 site in Democratic Republic of the Congo.
Trial summary
In this Cross-sectional study, we will analyzed data from a tertiary referral Congolese hospital to find whether or not Congolese patients with hypertensive heart disease have multiple comorbid conditions. Will report on the management and outcomes of the patients. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Hypertensive Heart Disease
- How many people
- 400 participants
- Where
- 1 siteDemocratic Republic of the Congo
- Study dates
- 26 Jul 2024to 29 Jul 2024
- How long will I take part?
- 1 Day
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Adult, Older adult
Study population: All patients 18 year or older diagnosed with hypertensive heart disease at Monkole Mother and Infant Hospital Center from January to December 2019
Who may be able to join
- Patients is 18 year or older
- Patient is diagnosed with hypertensive heart disease
Who cannot join
- Patient is not 18 year or older
- Patient is not diagnosed with hypertensive heart disease
Trial locations and contacts
1 site in 1 country.
Democratic Republic of the Congo1 site, 1 recruiting
- Recruiting
Monkole Mother and Infant Hospital Center
Kinshasa
Raïssa K Kongue, MD, raissakuembovekongue@gmail.com
Cody M Dinganga, MD, codymalaika@yahoo.fr
About this study
Official title: Comorbidities and the Management of Hypertensive Heart Disease in a Low-Resource Setting: A Cross-Sectional Study
In this Cross-sectional study, we will analyzed data from a tertiary referral Congolese hospital to find whether or not Congolese patients with hypertensive heart disease have multiple comorbid conditions. Will report on the management and outcomes of the patients.
Read the detailed description
This will be done by collecting individual data on BMI, dyslipidemia, stroke, diabetes, serum creatinine, HDL, LDL, and urea levels for patients diagnosed with hypertensive heart disease.
- Conditions
- Hypertensive Heart Disease
- Keywords
- Comorbidities, Democratic Republic of Congo, Hypertensive heart disease, Management
What is being measured
The primary outcome is the main question the study is designed to answer.
High Systolic Blood Pressure
The study will use high systolic blood pressures as a measure for hypertensive heart disease.
Measured: 1 month
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted29 Jul 2024
- Study start26 Jul 2024 (estimated)
- Primary completion28 Jul 2024 (estimated)
- Study completion29 Jul 2024 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Hypertensive Heart DiseaseStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Cross-sectional
- Enrolment
- 400 participants (estimated)
- Target duration
- 1 Day
Sponsor and investigators
- Lead sponsor
- Association of Future African Neurosurgeons, Yaounde, Cameroon
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Raïssa K Kongue, MD, Principal investigator, Faculty of Medicine, Bel Campus University of Technology, Kinshasa, Democratic Republic of Congo
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06524440
- Sponsor's protocol ID
- AAfricanNeuro
- Status last verified
- Jul 2024
- First submitted
- 24 Jul 2024
- Last updated
- 29 Jul 2024
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: The IPD from this study will be openly available in the Open Science Framework.
Study at a glance
From the registry record, last updated by the sponsor on 29 Jul 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Comorbidities and the Management of Hypertensive Heart Disease in a Low-Resource Setting: A Cross-Sectional Study
- ClinicalTrials.gov ID
- NCT06524440
- Acronym / sponsor ID
- AAfricanNeuro
- Conditions
- Hypertensive Heart Disease
- Keywords
- Comorbidities, Democratic Republic of Congo, Hypertensive heart disease, Management
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 400 participants (estimated)
- Lead sponsor
- Association of Future African Neurosurgeons, Yaounde, CameroonUniversity, hospital or other
- Study start
- 26 Jul 2024 (estimated)
- Primary completion
- 28 Jul 2024 (estimated)
- Study completion
- 29 Jul 2024 (estimated)
- First posted
- 29 Jul 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
In this Cross-sectional study, we will analyzed data from a tertiary referral Congolese hospital to find whether or not Congolese patients with hypertensive heart disease have multiple comorbid conditions. Will report on the management and outcomes of the patients.
Detailed description
This will be done by collecting individual data on BMI, dyslipidemia, stroke, diabetes, serum creatinine, HDL, LDL, and urea levels for patients diagnosed with hypertensive heart disease.
Study design
- Observational model
- Cohort
- Time perspective
- Cross-sectional
- Target follow-up
- 1 Day
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Age groups
- Adult, Older adult
- Study population
- All patients 18 year or older diagnosed with hypertensive heart disease at Monkole Mother and Infant Hospital Center from January to December 2019
Key inclusion criteria (2 listed)
- Patients is 18 year or older
- Patient is diagnosed with hypertensive heart disease
Key exclusion criteria (2 listed)
- Patient is not 18 year or older
- Patient is not diagnosed with hypertensive heart disease
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
High Systolic Blood Pressure
Time frame: 1 month
The study will use high systolic blood pressures as a measure for hypertensive heart disease.
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 29 Jul 2024.
- Individual participant dataSharing planned: Yes. The IPD from this study will be openly available in the Open Science Framework.
Related trials for Hypertensive Heart Disease
Recruiting
Community Health Worker Support to Lower Blood Pressure After a Pregnancy With High Blood Pressure
Pregnancy-Associated Hypertension, Gestational Hypertension
RecruitingPhase 2
Cardiac Effects of Mineralocorticoid Receptor Antagonism After Hypertensive Disorders of Pregnancy
Hypertension
Active, not recruiting
Eliminating Severe Maternal Morbidity With Heart Health Doulas Trial
Preeclampsia, Hypertensive Disorder of Pregnancy
Not yet recruiting
Sacubitril/Valsartan Versus Valsartan Alone on Left Atrial Volume Index in Hypertensive Patients
Hypertension, Left Ventricular Diastolic Dysfunction
RecruitingObservational study
Can Exercise Electrocardiography Discriminate Hypertensive Heart Disease From Obstructive Coronary Artery Disease? A Multimodality Imaging Study
Obstructive Coronary Artery Disease, Left Ventricular Hypertrophy
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Raïssa K Kongue, MD principal investigator
Faculty of Medicine, Bel Campus University of Technology, Kinshasa, Democratic Republic of Congo
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Hypertensive Heart Disease, run by Association of Future African Neurosurgeons, Yaounde, Cameroon at 1 site in Democratic Republic of the Congo.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 29 Jul 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Democratic Republic of the Congo. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Ulrick S Kanmounye, MD(c) (781 658 4443 ext. +1, ulricksidney@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
High Systolic Blood Pressure (time frame: 1 month). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Jul 2024.